60
Participants
Start Date
September 13, 2021
Primary Completion Date
May 31, 2025
Study Completion Date
August 31, 2026
Seton Placement
This treatment consists of inserting a seton (a soft flexible tube or nonabsorbable string) into the subject's perianal fistula. The seton will be removed by a study doctor at study visits as applicable.
AVB-114
AVB-114 consists of stem cells taken from a subject's fat tissue seeded into a bioabsorbable plug. AVB-114 will be inserted into the subject's fistula by a study doctor on Day 0.
NYU Langone Health, New York
Weill Cornell Medical College - NY Presbyterian Hospital, New York
Mayo Clinic Jacksonville, Jacksonville
University of Miami, Miami
Vanderbilt University Medical Center, Nashville
University of Cincinnati, Cincinnati
Indiana University Health University Hospital, Indianapolis
Mayo Clinic, Rochester
UChicago Medicine and Biological Sciences, Chicago
University of Colorado School of Medicine, Aurora
Mayo Clinic Arizona, Phoenix
Office of Phillip Fleshner, MD, Los Angeles
Stanford University, Redwood City
UC Davis, Sacramento
Mass Gen Hospital, Boston
Lead Sponsor
Collaborators (1)
Alimentiv Inc.
OTHER
Avobis Bio, LLC
INDUSTRY